Kiniksa Pharmaceuticals Stock (NASDAQ: KNSA) stock price, news, charts, stock research, profile.
Open | $25.07 |
Close | $25.91 |
Volume / Avg. | 871.68K / 462.19K |
Day Range | 25.07 - 27.10 |
52 Wk Range | 14.12 - 27.88 |
Market Cap | $1.83B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 75 |
Short Interest | 12.65% |
Days to Cover | 9.03 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Kiniksa Pharmaceuticals (NASDAQ:KNSA) through any online brokerage.
Other companies in Kiniksa Pharmaceuticals’s space includes: Syndax Pharmaceuticals (NASDAQ:SNDX), Bicycle Therapeutics (NASDAQ:BCYC), Nurix Therapeutics (NASDAQ:NRIX), BioCryst Pharma (NASDAQ:BCRX) and Novavax (NASDAQ:NVAX).
There is no analysis for Kiniksa Pharmaceuticals.
Kiniksa Pharmaceuticals has a consensus price target of $32.33.
The stock price for Kiniksa Pharmaceuticals (NASDAQ: KNSA) is $25.75 last updated July 25, 2024 at 7:46 PM EDT.
There are no upcoming dividends for Kiniksa Pharmaceuticals.
Kiniksa Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, July 23, 2024.
There is no upcoming split for Kiniksa Pharmaceuticals.
Kiniksa Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.